Welcome to this overview of the Institute’s achievements across 2023-2024. This period saw the Institute undergo a quinquennial review (QQR) by BBSRC in which we reported on the achievements from our 2017- 2024 funding round and presented our future research vision and plans for 2024-2028. This is summarised in the section: Life sciences research for lifelong health. You will also find feature articles on our three strategic research programmes, sharing perspectives from Gavin Kelsey (Epigenetics), Martin Turner (Immunology) and myself (Signalling).
The QQR was a huge effort from teams across the Institute and I am immensely proud of the outcomes. Our research programmes were all ranked as ‘high international’ or 'internationally leading’ and we received an award of £48m in strategic funding from BBSRC to support our research from 2024-20281. I am excited about our overarching theme of ‘proteostasis across the life course’, which connects our three research programmes and shapes our evolving global collaborations.
Beyond the QQR, this review also features more personal stories from across the Institute, sharing our big ambitions, reflecting on going further, doing more and our commitment to support success and make a difference. These demonstrate the achievements, excellence and dedication from teams within our community.
Read the report’s Director’s welcome in full, covering Our People, Our Science, Our Culture and Our Impact in 2023-2024 or browse the report sections.
Read the report welcome in full and browse the Institute photo album.
Read about the overarching aim of our 2024-2028 research plans.
Key stats on knowledge exchange and commercialisation, training, funding, public engagement, publications and PhD completions.
Highlights from the Institute illustrating excellence, impact, discovery, culture and how we share our science.
Celebrating individual awards and achievements within the Institute community.
Progress and research highlights from the Immunology research programme in 2023 and 2024.
Progress and research highlights from the Signalling research programme in 2023 and 2024.
Progress and research highlights from the Epigenetics research programme in 2023 and 2024.
Spotlighting the Institute's Imaging, Flow Cytometry and Genomics facilities to illustrate how they continue to follow leading innovations in their fields.
Sharing how the Institute fosters innovation at the Babraham Research Campus by driving translational research and entrepreneurial initiatives, supporting early-stage companies through access to state-of-the-art facilities, and building impact-driven collaborations with industry.
Our research features take a more in-depth look at selected aspects of our research and the wider impacts of our science for the wider world.
A look ahead for our discovery research, facilities development, role in national networks and commitment to responsible and sustainable science.